Assessment of Cytotoxicity, Genotoxicity
1 other identifier
observational
60
1 country
1
Brief Summary
Goal: The goal of this observational study is to evaluate the genotoxic and cytotoxic effects of OPG and CBCT on exfoliated buccal mucosal cells Main question: Does CBCT cause greater genotoxic and cytotoxic effects on buccal mucosal cells compared with OPG? Buccal epithelial cells were gently exfoliated from participants scheduled to undergo OPG or CBCT imaging. Samples were collected twice-immediately before exposure and again 10-12 days afterward. All participants provided written informed consent prior to inclusion in the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2025
CompletedFirst Submitted
Initial submission to the registry
November 22, 2025
CompletedFirst Posted
Study publicly available on registry
January 9, 2026
CompletedJanuary 9, 2026
January 1, 2026
9 months
November 22, 2025
January 2, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Primary outcome: Change in micronucleated buccal epithelial cells measured by the Buccal Micronucleus Cytome Assay (MN per 2,000 cells)
Micronucleated buccal epithelial cells will be quantified using the Buccal Micronucleus Cytome Assay following Sarto et al. (1987) criteria. For each participant, 2,000 exfoliated buccal cells will be evaluated at two time points: 1. immediately before dental X-ray exposure, and 2. approximately 10 ± 2 days after exposure. The primary analysis will report the change in the number of micronucleated cells per 2,000 cells (post-pre difference). Micronuclei are identified based on size, morphology, staining characteristics, and separation from the main nucleus. Higher post-pre values indicate greater genotoxic response.
10 ±12 days after exposure
Study Arms (4)
OPG,15-25 years old
CBCT,15-25 years old
OPG,40-50 years old
CBCT,40-50 years old
Eligibility Criteria
Adults aged 15-25 years and 40-50 years undergoing routine dental radiographic examination (OPG or CBCT), with follow-up buccal cell sampling for cytogenetic analysis.
You may qualify if:
- Underwent routine dental imaging using OPG or CBCT (no additional radiation for research purposes).
- Age 15-25 years or 40-50 years at the time of enrolment.
- Able and willing to provide written informed consent (or consent from a legal guardian for minors).
- Agreed to provide pre-exposure and follow-up buccal epithelial cell samples.
You may not qualify if:
- History of systemic diseases, including but not limited to leukemia, lymphoma, rheumatic disorders, or diabetes mellitus.
- Prior exposure to head-and-neck radiotherapy, immunosuppressive drugs, or cytotoxic medications.
- Presence of active infectious diseases or acute/chronic inflammatory conditions at the time of enrolment.
- Clinically visible oral pathological lesions, including mucosal abnormalities, gingivitis, or periodontitis.
- Use of removable intra-oral prostheses or appliances (e.g., dentures, orthodontic appliances).
- Engagement in smoking, alcohol consumption, or betel-nut chewing.
- Diagnostic or therapeutic X-ray exposure within the preceding 3 months.
- Previous or current oral mucosal diseases, including oral lichen planus, recurrent aphthous stomatitis, oral candidiasis, HSV infection, leukoplakia, oropharyngeal carcinoma, mucous membrane pemphigoid, or pemphigus vulgaris.
- Presence of persistent local irritants, including ill-fitting dental prostheses, sharp teeth/restorations, chemical irritation (acidic foods, alcohol-based mouthwash), or recurrent thermal injury.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Yaxin Wanglead
Study Sites (1)
universiti Sains Malaysia hospital
Kota Bharu, Kelantan, 25000, Malaysia
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- master
Study Record Dates
First Submitted
November 22, 2025
First Posted
January 9, 2026
Study Start
October 1, 2024
Primary Completion
July 1, 2025
Study Completion
September 30, 2025
Last Updated
January 9, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will not share